Kopran Ltd share price logo

Kopran Share Price (KOPRAN)

Check the latest share price of Kopran, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹196.472.47%

as on 04:01PM, 13 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Kopran Stock Performance

Get live Kopran share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹195.56
    Day's Price Range
    ₹200.05
  • 52 Week's Low

    52 Week's High

    ₹155
    52-Week Price Range
    ₹369.7
1 Month Return+ 1.68 %
3 Month Return+ 23.92 %
1 Year Return-24.18 %
3 Year Return-10.9 %
5 Year Return+ 487.35 %
Previous Close₹201.45
Open₹199.00
Volume2.34L
Upper Circuit₹241.74
Lower Circuit₹161.16

Kopran Fundamentals & Key Indicators

Check Kopran market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹948.67 Cr

Return on Equity (ROE)

8.53

PE Ratio (TTM)

24.56

Return on capital employed (ROCE)

11.24

Industry PE ratio

57.39

Beta (LTM)

1.43

P/B Ratio

2.99

Dividend Yield

1.16

PEG Ratio

-9.52

Quarterly Earnings Growth YOY

-48.01

EPS (TTM)

10.57

Sector

Pharmaceuticals

Book Value

101.9

Technical Analysis

How to invest in Kopran?

Investing in Kopran is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Kopran or KOPRAN on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Kopran or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Kopran with just a few clicks!

Kopran Stock's Interest Amongst Investors

74%

Period Jun 14, 2025 to May 15, 2025. Change in 30 Days vs previous period

Search interest for Kopran Ltd Stock has increased by 74% in the last 30 days, reflecting an upward trend in search activity.

Kopran Valuation

Track how Kopran P/E has moved over time to understand its valuation trends.

Kopran in the last 5 years

  • Overview

  • Trends

Lowest (3.00x)

March 24, 2020

Today (24.56x)

June 13, 2025

Industry (57.39x)

June 13, 2025

Highest (53.33x)

September 5, 2023

LowHigh

Today’s Price to Earnings Ratio: 24.56x

Kopran Financial Results

Get the annual and quarterly financial summary of Kopran, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

186 (0%)139 (25%)152 (9%)166 (10%)172 (4%)
Net Income

(in ₹ Cr)

19 (0%)11 (40%)7 (34%)10 (41%)10 (7%)
Net Profit Margin10.01% (0%)7.96% (20%)4.87% (39%)6.26% (29%)5.62% (10%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

326 (0%)465 (43%)507 (9%)513 (1%)
Total Liabilities

(in ₹ Cr)

80 (0%)87 (9%)112 (29%)96 (14%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

10 (0%)49 (389%)-38 (178%)17 (145%)35 (107%)

Indices Featuring Kopran Stock

Check stock indices that include Kopran.

BSE Small-Cap

₹53,370.29

-0.3 (-161.18%)

BSE Healthcare

₹43,995.31

0.08 (34.42%)

Kopran Earnings and Dividends

View detailed summary of the earnings and dividend history of Kopran.

  • Kopran Ltd Earnings Results

    Kopran Ltd’s net profit fell -48.01% since last year same period to ₹9.68Cr in the Q4 2024-2025. On a quarterly growth basis, Kopran Ltd has generated -6.92% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Kopran Ltd Dividends May,2024

    In the quarter ending March 2024, Kopran Ltd has declared dividend of ₹3 - translating a dividend yield of 3.05%.

    Read More about Dividends

Kopran Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Kopran.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
44.42%
0.00
Foreign Institutions
1.12%
0.00
Mutual Funds
0%
0.00
Retail Investors
54.45%
0.00
Others
0%
0.00

Kopran vs Peers

Compare market cap, revenue, PE, and other key metrics of Kopran with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA948.6797.47%0.5350614
NA6.245.19%5.69NANA
NA81.5858.65%0.51140
NA1,949.0625.81%0.5158630
NA69.916.88%0.78245

Kopran News & Key Events

Latest news and events in one place to help you make informed investing decisions in Kopran.

  • Kopran Reports Significant Profit Declines in March 2025 - 15 May, 2025

    Kopran Ltd reported a substantial decline in both standalone and consolidated net profits for the March 2025 quarter, with standalone net sales down 15.02% and consolidated sales down 7.37%. Overall, the company's financial performance reflects ongoing challenges.
  • Kopran Stock Rises After Successful USFDA Inspection - 28 Apr, 2025

    Kopran's stock surged 4.39% following a successful USFDA inspection at its subsidiary's API facility, which concluded without any observations. The company reported a 34.14% decline in net profit for Q3 December 2024.
  • Kopran Stake Increase Amid Stock Decline - 26 Apr, 2025

    Kela increased his stake in Kopran to 1.46%, up from 1.04%. However, the stock has faced significant declines, falling 11% year-to-date and 25% over the past year.
  • Kopran Ltd Shows Strong Growth and Upcoming Merger - 16 Apr, 2025

    Kopran Ltd has demonstrated significant sales and profit growth, with a 578% increase in share price since April 2020. The company plans to merge with Kopran Laboratories Limited, enhancing its market position.

Insights on Kopran Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.86% to 1.12% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 142.06 Cr → 175.62 Cr (in ₹), with an average increase of 6.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 69.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 142.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 54.67% to 54.45% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, KOPRAN stock has moved down by -10.9%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 44.45% to 44.42% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 10.4 Cr → 9.68 Cr (in ₹), with an average decrease of 6.9% per quarter

About Kopran

Kopran, a pharmaceutical company controlled by Parijat Enterprises and promoted by Somani group, came out with a public issue in Nov.92 to finance its backward integration project and expand its antibiotic facility. Its bulk drug plant is approved by the US FDA and UK regulatory authorities, and in 1995 they were awarded Quality Excellence award by Indian Drug Manufacturers Association. Kopran manufactures penicillin and amoxycillin and has collaborations with Germany, South Korea, US and Adac Laboratories.They launched new products for therapeutic groups like asthma, cardiology, diabetes and lifestyle and obtained approval from European Directorate for Quality of Medicines and UK MHRA. Furthermore, they increased their installed capacity of liquids by 3.00 lakhs of liters and tablets/capsules by 270 croresNos during 2001. They also had tied up with EMerck for comarketing a new antiinflammatory drug in India and subsequently launched Cholestat Atorvastatin. Kopran has a high growth rate in exports and has been ranked amongst the top few fastest growing companies in IndiaORG Marg June 2000.

Revenue: ₹172.36Cr as on March 2025 (Q4 FY25)
Net Profit: ₹9.68Cr as on March 2025 (Q4 FY25)
Listing date: 01 Dec, 1994
Chairperson Name: Susheel Somani
OrganisationKopran Ltd
IndustryPharmaceuticals
CEOSusheel Somani
E-voting on sharesClick here to vote

Mutual Funds that own Kopran

Check out the Mutual Funds with significant holdings in Kopran.

FAQs

What is Kopran share price today?

Kopran share price today stands at ₹196.47, Open: ₹199, Previous Close: ₹201.45, High: ₹200.05, Low: ₹195.56, 52 Week High: ₹369.7, 52 Week Low: ₹155.

What is today's traded volume of Kopran?

Today's traded volume of Kopran is 2.34L. Which means that 2.34L shares of Kopran were bought and sold on the stock market during today's trading session.

What is Kopran's market cap today?

Today's market capitalisation of Kopran is ₹948.67 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Kopran?

Kopran’s 52 week high is ₹369.7 and 52 week low is ₹155. The current share price of Kopran is ₹196.47, which is -46.86% down from its 52 week high and 26.75% up from its 52 week low.